Breast Cancer Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- Participants must be over 18 years of age.
- The breast tumor must have been confirmed as invasive cancer through a core biopsy (a tissue sample taken with a needle).
- The tumor must meet one of these size or stage conditions: shrinkage of the tumor is needed to make complete surgical removal possible; or shrinkage is needed to allow breast-conserving surgery; or, for tumors that are hormone receptor-positive and HER2-negative, the cancer is at stage IIB to IIIC; or, for tumors that are hormone receptor-negative, the cancer is at stage IIA to IIIC. (Note: people with locally advanced cancer that cannot currently be removed by surgery may also be considered if complete surgical removal later is a realistic goal — confirm with trial site.)
- Participants must be in good general health, rated 0 or 1 on a standard medical scale called ECOG (meaning fully active or able to carry out light work).
- Blood cell counts must meet minimum levels: white blood cells (neutrophils) at 1.5 G/l or above, platelets at 100 G/l or above, and haemoglobin at 10 g/dl or above.
- Liver enzyme levels (ALT and AST) must be no more than 1.5 times the upper limit of the normal range.
- Bilirubin (a substance processed by the liver) must be below 1.5 times the upper limit of the normal range, except for people with a condition called Gilbert's disease, where the limit is 3 times the upper limit.
- Kidney function must be adequate, shown by creatinine levels below 1.5 times the upper limit of the normal range, or a kidney filtration rate (eGFR) above 60 ml/min.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People with confirmed or suspected cancer that has spread to distant parts of the body.
- People who have not had the required tests to check for cancer spread — at minimum, a chest X-ray and abdominal ultrasound must have been done (CT scans of the chest, abdomen, and pelvis, plus a bone scan or PET/CT, are preferred where lymph nodes are involved).
- People with known serious heart conditions, including significant abnormal heart rhythms, a heart attack or unstable chest pain within the past 6 months, untreated heart failure, long QT syndrome, or a heart failure rating of NYHA class II or above.
- People with other serious ongoing physical or mental health conditions, or significant abnormal test results, that the treating doctor considers would make chemotherapy too risky.
- People who are pregnant, or who are not willing to use a suitable non-hormonal method of contraception during the trial.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Gabor Rubovszky, NIO Hungary
Phone: +3612248600
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.
Where this trial is recruiting
Primary endpoints
pathological complete remission rate
Can't join this trial?
Data last synced from ClinicalTrials.gov: 7 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.